Takeda Pharmaceutical (TAK) Receivables - Other: 2018-2025
- Takeda Pharmaceutical's Receivables - Other rose 0.76% to $380.5 million in Q1 2025 from the same period last year, while for Mar 2025 it was $380.5 million, marking a year-over-year increase of 0.76%. This contributed to the annual value of $381.1 million for FY2025, which is 1.80% down from last year.
- As of Q1 2025, Takeda Pharmaceutical's Receivables - Other stood at $380.5 million, which was up 0.76% from $377.6 million recorded in Q1 2024.
- In the past 5 years, Takeda Pharmaceutical's Receivables - Other registered a high of $714.3 million during Q1 2021, and its lowest value of $377.6 million during Q1 2024.
- For the 3-year period, Takeda Pharmaceutical's Receivables - Other averaged around $439.2 million, with its median value being $380.5 million (2025).
- In the last 5 years, Takeda Pharmaceutical's Receivables - Other plummeted by 32.50% in 2024 and then climbed by 0.76% in 2025.
- Quarterly analysis of 5 years shows Takeda Pharmaceutical's Receivables - Other stood at $714.3 million in 2021, then decreased by 4.68% to $680.9 million in 2022, then declined by 17.84% to $559.4 million in 2023, then plummeted by 32.50% to $377.6 million in 2024, then grew by 0.76% to $380.5 million in 2025.
- Its Receivables - Other stands at $380.5 million for Q1 2025, versus $377.6 million for Q1 2024 and $559.4 million for Q1 2023.
